Investment & M&A transaction comps
Supplements Investment & M&A Transaction Comps
Explore investment and M&A transactions tagged supplements. Compare companies, buyers, dates and available valuation multiples, with reported, estimated or rumored figures clearly labelled in each comp.
Coverage includes published FundComb transactions carrying this tag. Each comp preserves its own source notes and valuation basis.
- Reviewed transactions
- 71
- With value data
- 42
- With revenue multiples
- 36
- Transaction years
- 2005–2026
Sortable transaction comps
Supplements transaction table
Rows with reported value
16 / 21
Acquisition EV, USD
USD 43B
Investment EV, USD
-
Median EV / revenue
3.6x
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
21 shown of 71 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately, and a financing without a reported valuation shows its amount raised, not an EV.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Quest Nutrition Control | 2019-08-22 | The Simply Good Foods Company | USD 1.0B Consideration | 1,000 | 2.9x | 17.4x | United States | Estimated 1 source | ||
| OLLY Nutrition Control | 2019-04-18 | Unilever | Undisclosed Undisclosed | Undisclosed | 5.0x | 20.0x | United States | Confirmed 1 source | ||
| Pfizer Consumer Healthcare Control (68%) | 2018-12-19 | GlaxoSmithKline (GSK-Pfizer consumer joint venture) | Undisclosed | Undisclosed | - | - | United States & Global | Estimated 1 source | ||
| GSK Consumer Healthcare India (Horlicks) Control (100%) | 2018-12-03 | Hindustan Unilever and Unilever | EUR 5.3B Consideration | 5,999 | 9.6x | - | India, Bangladesh & Asian Markets | Confirmed 1 source | ||
| Probiotics International Control | 2018-07-02 | ADM | USD 243M Consideration | 243 | 5.6x | 21.2x | United Kingdom | Estimated 2 sources | ||
| Nutranext Control | 2018-03-12 | Clorox | USD 700M Consideration | 700 | 3.5x | 14.0x | - | Estimated 1 source | ||
| Life-Space Group Control (100%) | 2018-01-31 | BY-HEALTH Co., Ltd. | AUD 670M Enterprise Value | 543 | - | - | Australia | Estimated 1 source | ||
| BioCare Copenhagen Control (20%) | 2017-12-22 | DSM | Undisclosed Undisclosed | Undisclosed | - | - | Denmark | Confirmed 1 source | ||
| Atrium Innovations Control | 2017-12-05 | Nestlé | USD 2.3B Consideration | 2,300 | 3.3x | 19.0x | - | Confirmed 1 source | ||
| Ganeden Control | 2017-10-11 | Kerry Group | Undisclosed | Undisclosed | 6.0x | 20.0x | - | Confirmed 1 source | ||
| Chicago Bar Company LLC (RXBAR) Control | 2017-10-06 | Kellogg Company | USD 600M Enterprise Value | 600 | 5.0x | 19.5x | United States | Confirmed 4 sources | ||
| Nutraceutical Control | 2017-05-22 | HGGC | USD 446M Enterprise Value | 446 | 1.8x | 9.9x | - | Confirmed 2 sources | ||
| Viviscal Control | 2017-01-20 | Church & Dwight | EUR 150M Consideration | 159 | 3.6x | 17.8x | - | Confirmed 2 sources | ||
| Vitaco Control | 2016-08-01 | Primavera Capital | AUD 345M Enterprise Value | 261 | 1.5x | 14.7x | Australia/New Zealand | Confirmed 1 source | ||
| Nutraceutix assets Control (100%) | 2016-06-06 | Probi AB | USD 105M Enterprise Value | 105 | 3.1x | 13.1x | United States | Confirmed 1 source | ||
| Swisse Control (83%) | 2015-09-17 | Biostime | AUD 1.7B Enterprise Value | 1,197 | 3.6x | 10.2x | Australia | Confirmed 3 sources | ||
| Atrium Innovations Inc. Control | 2013-11-29 | Permira Advisers Ltd. | USD 1.0B Enterprise Value | 1,036 | - | 10.8x | Canada | Estimated 3 sources | ||
| Schiff Nutrition Control | 2012-11-22 | Reckitt Benckiser | USD 1.4B Enterprise Value | 1,400 | 4.2x | 19.1x | - | Confirmed 3 sources | ||
| Avid Health, Inc. Control | 2012-08-20 | Church & Dwight Co., Inc. | USD 650M Enterprise Value | 650 | 2.8x | 11.2x | - | Estimated 5 sources | ||
| DuPont Nutrition & Biosciences Control | 2005-07-01 | International Flavors & Fragrances (IFF) | USD 26B Consideration | 26,200 | 4.3x | 18.9x | United States | Estimated 2 sources | ||
| Agro Biosciences, Inc. Control | - | Church & Dwight | Undisclosed | Undisclosed | - | - | - | Confirmed 15 sources |
Explore related tags
Continue to the full transaction history for each tag.
Explore buyers & investors
Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.